Development and characterization of a patient‑derived orthotopic xenograft of therapy‑resistant breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development and characterization of a patient‑derived orthotopic xenograft of therapy‑resistant breast cancer

Published:2023-03-27 Issue:5 Volume:49 Page:
ISSN:1021-335X
Container-title:Oncology Reports
language:
Short-container-title:Oncol Rep

Author:

Butti Ramesh¹,Kapse Prachi¹,Bhadauriya Garima¹,Ahmad Suhail²,Chaubal Rohan³,Parab Pallavi³,Kadam Rasika⁴,Mahapatra Soumya⁵,Shet Tanuja³,Dutt Amit²,Gupta Sudeep³,Kundu Gopal¹

Affiliation:

1. Laboratory of Tumor Biology, Angiogenesis and Nanomedicine Research, National Centre for Cell Science, Pune, Maharashtra 411007, India

2. Integrated Cancer Genomics Laboratory, Tata Memorial Centre‑Advanced Centre for Treatment, Research and Education in Cancer (TMC‑ACTREC), Navi Mumbai, Maharashtra 410210, Israel

3. Homi Bhabha National Institute, Training School Complex, Mumbai 400094, India

4. Clinical Genomics and Hypoxia Lab (Clinician Scientist Lab), TMC‑ACTREC, Navi Mumbai, Maharashtra 410210, India

5. School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT) Deemed to be University, Bhubaneswar, Odisha 751024, Israel

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,General Medicine

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in breast cancer cell line research;International Journal of Cancer;2024-01-17

2. Capecitabine/exemestane/tamoxifen;Reactions Weekly;2023-05-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP